A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)

计划入组 120 人 · 首次发布于 2023 年 11 月 29 日

New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure Lowering

计划入组 70 人 · 首次发布于 2012 年 6 月 1 日

Effects of Angiotensin II Receptor Blocker Compared With Diuretics in High-risk Hypertensive Patients

计划入组 13,542 人 · 首次发布于 2009 年 11 月 11 日

Angiotensin II(Giapreza)

Angiotensin-II receptor antibody

Azilsartan medoxomil(Edarbyclor, Edarbi)

C₃₀H₂₄N₄O₈ · Rx

Arvinas Estrogen Receptor, Inc.

United States

Arvinas Androgen Receptor, Inc.

United States

Celgene International II SARL

Switzerland

Scienture Secures FDA Orange Book Patent Listing for ARBLI™ Losartan Potassium Oral Suspension

Dimerix's Phase 3 Trial of DMX-200 for FSGS Completes Part 2 Recruitment, Interim Analysis Expected in August 2025

Blood Pressure Drug Telmisartan Shows Promise in Enhancing Cancer Treatment Effectiveness